Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001510281-25-000178 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-04-03 | 2025-04-01+ | HQL | Weinstein Boaz | 10% | S - Sale | $12.34 | -46.7K | 3.14M | -1% | -$576.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | S | D | 17,621 | $12.45 | 3,170,784 | I - | — | — | |
| 2 | Common | Common Stock | 2025-04-02 | S | D | 29,102 | $12.28 | 3,141,682 | I - | — | — |